GSK-3 is a novel target of CREB and GSK-3-CREB signaling participates in cell survival in lung cancer

被引：0
|
作者：
Park, Sin-Aye [1 ]
Lee, Jong Woo [1 ]
Herbst, Roy S. [1 ]
Koo, Jaseok Peter [1 ]
机构：
[1] Yale Canc Ctr, New Haven, CT USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2094
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines
    Doble, Bradley W.
    Patel, Satish
    Wood, Geoffrey A.
    Kockeritz, Lisa K.
    Woodgett, James R.
    DEVELOPMENTAL CELL, 2007, 12 (06) : 957 - 971
  • [22] Molecular Mechanisms of Environmental Enrichment: Impairments in Akt/GSK3β, Neurotrophin-3 and CREB Signaling
    Hu, Yuan-Shih
    Long, Nancy
    Pigino, Gustavo
    Brady, Scott T.
    Lazarov, Orly
    PLOS ONE, 2013, 8 (05):
  • [23] Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation
    Aubry, Jean-Michel
    Schwald, Michele
    Ballmann, Eladia
    Karege, Felicien
    PSYCHOPHARMACOLOGY, 2009, 205 (03) : 419 - 429
  • [24] Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation
    Jean-Michel Aubry
    Michèle Schwald
    Eladia Ballmann
    Félicien Karege
    Psychopharmacology, 2009, 205 : 419 - 429
  • [25] AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation
    Zhaohua Tang
    Gang Yang
    Xiaoshu Wang
    Feilan Chen
    Zhengbu Liao
    Zhiwei Zhang
    Zili Liu
    Wenxin Zeng
    Min Fang
    Wentao Wang
    Xiaochuan Sun
    Gang Huo
    Journal of Neuro-Oncology, 2020, 149 : 231 - 242
  • [26] AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation
    Tang, Zhaohua
    Yang, Gang
    Wang, Xiaoshu
    Chen, Feilan
    Liao, Zhengbu
    Zhang, Zhiwei
    Liu, Zili
    Zeng, Wenxin
    Fang, Min
    Wang, Wentao
    Sun, Xiaochuan
    Huo, Gang
    JOURNAL OF NEURO-ONCOLOGY, 2020, 149 (02) : 231 - 242
  • [27] Deletion of GSK-3α, but Not GSK-3β, Defines an Essential Role in β-Adrenergic Responsiveness and Identifies a Novel Strategy for β-Blockade
    Zhou, Jibin
    Woulfe, Kathleen
    Chen, Xiongwen
    Gao, Erhe
    Fan, Qian
    Li, Yingxin
    Lal, Hind
    Farber, John L.
    Shang, Xiying
    Doble, Bradley W.
    MacAulay, Katrina
    Woodgett, James R.
    Force, Thomas L.
    CIRCULATION RESEARCH, 2009, 105 (12) : E56 - E56
  • [28] Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors
    Peat, AJ
    Boucheron, JA
    Dickerson, SH
    Garrido, D
    Mills, W
    Peckham, J
    Preugschat, F
    Smalley, T
    Schweiker, SL
    Wilson, JR
    Wang, TY
    Zhou, HQQ
    Thomson, SA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2121 - 2125
  • [29] Activator or inhibitor? GSK-3 as a new drug target
    Takahashi-Yanaga, Fumi
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (02) : 191 - 199
  • [30] The GSK-3 Family as Therapeutic Target for Myocardial Diseases
    Lal, Hind
    Ahmad, Firdos
    Woodgett, James
    Force, Thomas
    CIRCULATION RESEARCH, 2015, 116 (01) : 138 - 149
12345